|
Volumn 9, Issue 4, 1996, Pages 303-314
|
Ancrod: Understanding the agent
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANCROD;
ANTICOAGULANT AGENT;
BATROXOBIN;
DEXTRAN;
FIBRINOGEN;
HEPARIN;
MANNITOL;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SERINE PROTEINASE;
STREPTOKINASE;
THROMBIN;
UROKINASE;
VENOM ANTISERUM;
WARFARIN;
BLEEDING;
DEEP VEIN THROMBOSIS;
DOG;
DOSE RESPONSE;
DRUG CHOICE;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MECHANISM;
FIBRINOLYSIS;
GLOMERULONEPHRITIS;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
ISCHEMIC HEART DISEASE;
LUNG EMBOLISM;
NONHUMAN;
PERIPHERAL VASCULAR DISEASE;
PRIORITY JOURNAL;
REVIEW;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TERATOGENICITY;
THROMBOCYTOPENIA;
THROMBOSIS;
ANCROD;
ANIMALS;
ANTICOAGULANTS;
BLOOD COAGULATION;
CORONARY ARTERY BYPASS;
FIBRINOGEN;
FIBRINOLYSIS;
HEPARIN;
HUMANS;
PULMONARY EMBOLISM;
THROMBOCYTOPENIA;
THROMBOSIS;
VASCULAR SURGICAL PROCEDURES;
|
EID: 0029850599
PISSN: 08957967
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (0)
|